Trials / Completed
CompletedNCT05572125
Iron Therapy in Erythropoietic Protoporphyria
Oral Iron Therapy in Erythropoietic Protoporphyria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Giving oral iron to patients with erythropoietic protoporphyria (EPP) who is iron deficient is thought to be beneficial. This is, however, not well documented. The purpose of this study is to investigate the effect and safety of oral iron in patients with EPP who is taking iron tablets due to iron deficiency.
Conditions
Timeline
- Start date
- 2022-10-17
- Primary completion
- 2023-02-14
- Completion
- 2023-02-14
- First posted
- 2022-10-07
- Last updated
- 2023-02-23
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05572125. Inclusion in this directory is not an endorsement.